Align Technology, Inc. (ALGN) analyst actions
Rating and price-target actions on ALGN in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the ALGN overview →
3 measured ALGN analyst action events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Align Technology, Inc. (ALGN) And Encourages Shareholders to Reach Out | Press release | -0.04% | -0.06% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Align Technology, Inc. (ALGN) And Encourages Stockholders to Reach Out | Press release | +0.04% | — | |
| Align Technology Initiates Patent Infringement Ligitation Against Angelalign Technology | Press release | -0.10% | — |
Keep exploring
More ALGN: earnings → · SEC filings → · ALGN overview →
Other Healthcare names and their analyst actions
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Verastem, Inc. (VSTM) | 411 | -0.09% | 48% |
| Alphatec Holdings, Inc. (ATEC) | 409 | -0.18% | 45% |
| ALLIQUA BIOMEDICAL (ALQA) | 407 | -0.11% | 43% |
| NeoGenomics, Inc. (NEO) | 406 | -0.22% | 44% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its analyst actions — that is what the link opens.